The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9062043, Table 11, Compound 3 ID: ALA3696948
PubChem CID: 57664222
Max Phase: Preclinical
Molecular Formula: C18H21N3O3S
Molecular Weight: 359.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCCCO)c1ccc2c(c1)nc(NCCCO)c1ccsc12
Standard InChI: InChI=1S/C18H21N3O3S/c22-8-1-6-19-17-14-5-10-25-16(14)13-4-3-12(11-15(13)21-17)18(24)20-7-2-9-23/h3-5,10-11,22-23H,1-2,6-9H2,(H,19,21)(H,20,24)
Standard InChI Key: NMTBSSZOVGFFHA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
5.1877 -7.2109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1894 -6.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8912 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1953 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1932 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4914 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4892 -5.2578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5272 -5.8600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0114 1.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4013 3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9095 2.9665 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
6 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
15 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 11 1 0
25 21 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.45Molecular Weight (Monoisotopic): 359.1304AlogP: 2.36#Rotatable Bonds: 8Polar Surface Area: 94.48Molecular Species: NEUTRALHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.24CX LogP: 0.89CX LogD: 0.89Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.46Np Likeness Score: -1.42
References 1. (2015) Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators,